Molecular and cellular effects of bortezomib on Epstein-Barr virus positive nasopharyngeal carcinoma
Nasopharyngeal carcinoma (NPC) is a common cancer in Southeast Asia. While external radiotherapy is the mainstay of treatment, adjuvant chemotherapy is required in advanced disease. Current chemotherapy heavily relies on cisplatin and docetaxel. The disease relapse rate is relatively high with poor...
Main Authors: | Lam, Heung-wing, Benjamin., 林向榮. |
---|---|
Language: | English |
Published: |
The University of Hong Kong (Pokfulam, Hong Kong)
2013
|
Subjects: | |
Online Access: | http://hdl.handle.net/10722/192787 |
Similar Items
-
Epstein-barr virus serology in the management of recurrent nasopharyngeal carcinoma
by: Chan, Yu-wai, et al.
Published: (2015) -
Sequence analysis of epstein-barr virus genomes in nasopharyngeal carcinoma
by: Kwok, Hin, et al.
Published: (2014) -
The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma
by: You Quan Li, et al.
Published: (2018-03-01) -
Characterization of aberrantly expressed microRNAs in Epstein-Barr virus-associated nasopharyngeal carcinoma.
Published: (2013) -
Epstein-barr virus (EBV) infection and STAT3 activation in nasopharyngeal epithelial cells
by: Zhang, Guitao, et al.
Published: (2015)